Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$903K Buy
2,566
+1,608
+168% +$573K 0.42% 28
2025
Q4
$314K Hold
958
0.17% 70
2025
Q3
$270K Hold
958
0.15% 74
2025
Q2
$267K Sell
958
-63
-6% -$17.8K 0.1% 84
2025
Q1
$318K Buy
+1,021
New +$301K 0.14% 73

Other funds holding AMGN

1248 Management's AMGN Position: Q1 2026 in Review

1248 Management increased its Amgen (AMGN) stake by 168% in Q1 2026, buying an estimated $573K and bringing the position to 2,566 shares worth $903K. The position accounts for 0.42% of the portfolio, ranked #28.

1248 Management first reported a position in AMGN in Q1 2025 and has held it in 5 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • 1248 Management held 2,566 shares of Amgen worth $903K as of Q1 2026.
  • 1248 Management bought 1,608 Amgen shares in Q1 2026, an estimated $573K.
  • Amgen made up 0.42% of 1248 Management's portfolio in Q1 2026, its #28 holding.
  • 1248 Management first reported a position in Amgen in Q1 2025 and has held it in 5 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on 1248 Management's 13F filing for Q1 2026, filed 15 May 2026.